All human blood and tissue samples were collected and analyzed with approved protocols in accordance with the ethical requirements and regulations of the Oregon Health & Science University (OHSU) institutional review board. Informed consent was obtained from all subjects. Peripheral blood was obtained from cancer patients diagnosed with PDAC at various stages and treated at OHSU, as well as from healthy controls. Identification and acquisition of solid tumor or peripheral blood biopsies from female patients who previously received a gender-mismatched bone marrow transplantation was conducted by screening of the Center for International Bone Marrow Transplant Registry.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.